Sittner & Nelson, LLC Gilead Sciences, Inc. Transaction History

Sittner & Nelson, LLC

$219 Million
Q3 2024

A detailed history of Sittner & Nelson, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sittner & Nelson, LLC holds 8,521 shares of GILD stock, worth $768,508. This represents 0.33% of its overall portfolio holdings.

Number of Shares

8,521

Previous 6,096 39.78%

Holding current value

$768,508

Previous $418,000 70.81%

% of portfolio

0.33%

Previous 0.21%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$66.59 - $83.99 $161,480 - $203,675	2,425 Added 39.78%	8,521 $714,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $47,109 - $54,368	-746 Reduced 10.9%	6,096 $418,000
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $51,251 - $62,499	716 Added 11.69%	6,842 $501,000
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $23,373 - $26,505	-319 Reduced 4.95%	6,126 $496,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $24,622 - $26,863	333 Added 5.45%	6,445 $482,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $15,734 - $17,946	-207 Reduced 3.28%	6,112 $471,000
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $168,845 - $192,366	-2,184 Reduced 25.69%	6,319 $524,000
Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $2,866 - $4,115	-46 Reduced 0.54%	8,503 $729,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $54,002 - $61,685	907 Added 11.87%	8,549 $527,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $108,455 - $122,153	1,879 Added 32.6%	7,642 $472,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $17,433 - $21,846	301 Added 5.51%	5,763 $343,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $648 - $736	10 Added 0.18%	5,462 $397,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $64,305 - $69,378	950 Added 21.1%	5,452 $381,000
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $19,041 - $20,805	300 Added 7.14%	4,502 $310,000
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $53,880 - $61,477	-898 Reduced 17.61%	4,202 $272,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $288,915 - $329,205	5,100 New	5,100 $297,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.

Account

Sittner & Nelson, LLC Gilead Sciences, Inc. Transaction History